Compounds > lamivudine
Page last updated: 2024-08-24

lamivudine and AIDS Seroconversion

lamivudine has been researched along with AIDS Seroconversion in 113 studies

Research

Studies (113)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's22 (19.47)18.2507
2000's39 (34.51)29.6817
2010's32 (28.32)24.3611
2020's20 (17.70)2.80

Authors

AuthorsStudies
de la Mora, L; García, F; Llibre, JM; Noguera-Julián, M; Paredes, R; Parera, M; Revollo, B; Viñuela, L1
Blanco, JR; de la Torre-Lima, J; Ferra, S; García-Vallecillos, C; Hidalgo-Tenorio, C; López-Lirola, A; López-Ruz, MÁ; Martínez, OJ; Montero, M; Omar, M; Palomares, J; Pasquau, J; Payeras, A; SanJoaquín, I; Terrón, A; Vinuesa, D1
Gan, X; Hui, X; Li, Q; Sun, W1
Abdi, B; Bitilinyu-Bangoh, JE; Calvez, V; Descamps, D; Jahn, A; Kalua, T; Lê, MP; Marcelin, AG; Nicholas, S; Ousley, J; Peytavin, G; Schramm, B; Storto, A; Szumilin, E; Temfack, E1
Cai, K; Chen, W; He, Y; Liu, X; Rao, M; Sun, L; Wang, H; Xu, L; Zhang, L; Zhao, F1
Cai, L; Guo, Z; He, S; Wang, Y; Wang, Z; Yan, D; Yang, X; Zheng, Y1
Chen, C; Hu, Y; Huang, J; Lv, R; Ma, P; Pei, X; Qi, M; Su, Y; Wei, H; Yan, L; Ye, Z; Zhong, M; Zou, M1
Baxter, C; Beyer, A; Derkach, E; Lobodina, A; Pyadushkina, E; Rozenberg, V; Ugrekhelidze, D1
Aurpibul, L; Best, BM; Campbell, H; Cassim, H; Cooper, E; Flynn, P; Gray, KP; Krotje, C; McCarthy, K; McFarland, E; Melvin, AJ; Moye, J; Ounchanum, P; Rungmaitree, S; Scheckter, R; Teppler, H; Tobin, NH; Townley, E; Wan, H; Yedla, M; Yee, KL1
Aghokeng, A; Ateba Ndongo, F; Bilong, S; Djeuda, ABD; Eboumbou Moukoko, CE; Eyoum Bille, B; Fokam, J; Grace, N; Koki Ndombo, P; Moukoko Mbonjo, M; Ndjolo, A; Penda, CI1
Evitt, LA; Grove, RA; Nanji, S; Okoli, C; Snedecor, SJ; van Wyk, J1
Buzón, L; De la Fuente, S; De Los Santos, I; Dueñas-Gutiérrez, C; Ferreira, E; Gómez, J; Iribarren, JA; Moran, MA; Moreno, E; Pedrero-Tomé, R; Pousada, G; Troya, J1
Brenner, BG; Ibanescu, RI; Oliveira, M; Routy, JP; Thomas, R1
Eleje, GU; Ikechebelu, JI; Nwagha, UI; Okafor, HU; Ugwu, AO; Ugwu, EO; Umeh, UA1
Ait-Khaled, M; Górgolas Hernández-Mora, M; Kinder, C; Lutz, T; Moodley, R; Moore, R; Parry, CM; Podzamczer, D; Saggu, P; Underwood, M; van Wyk, J; Wang, R; Wright, J; Wynne, B1
Ajeh, R; Beloumou, G; Bouba, NP; Cappelli, G; Ceccherini-Silberstein, F; Chenwi, CA; Colizzi, V; Dambaya, B; Djupsa, S; Fokam, J; Kembou, E; Mbanya, D; Ndjolo, A; Perno, CF; Santoro, MM; Semengue, ENJ; Takou, D; Tala, V; Teto, G1
Bellecave, P; d'Arminio Monforte, A; Egger, M; Gill, MJ; Günthard, HF; Hossmann, S; Ingle, SM; Kouyos, RD; Kusejko, K; Lessells, R; Loosli, T; Maartens, G; Mouton, J; Okhai, H; Sabin, CA; Stecher, M; Sterne, JAC; van Sighem, A1
Domínguez-Castro, M; Figueroa-Damián, R; Galindo-Sevilla, N; Hernández-Pineda, J; Irles, C; Jung-Cook, HH; Katende-Kyenda, NL; Ramírez-Ramírez, A; Romo-Yañéz, J1
Abdool Karim, Q; Dawood, H; Mansoor, LE; Matten, D; Naicker, CL; Naidoo, K; Singo, D; Williamson, C1
Baldin, G; Borghi, V; Capetti, A; Ciccullo, A; Cossu, MV; d'Ettorre, G; De Vito, A; Di Giambenedetto, S; Gennari, W; Giacomelli, A; Giacometti, A; Latini, A; Madeddu, G; Mussini, C; Rusconi, S; Sterrantino, G1
Berenguer Berenguer, J; Cenoz Gomis, S; Graefenhain, R; Lopez Sanchez-Cambronero, D; Losa García, JE; Martínez Sesmero, JM; Moreno Guillen, S; Parrondo Garcia, FJ1
Blanco, JL; Casadella, M; Clotet, B; de Lazzari, E; Gatell, JM; Mallolas, J; Martinez, E; Negredo, E; Paredes, R; Rojas, J1
Andreatta, K; Brar, I; Brinson, C; Cheng, A; Custodio, J; Liu, H; López-Cortés, L; Martin, H; Mills, A; Molina, JM; Podzamczer, D; Quirk, E; Ruane, P; Stellbrink, HJ; Ward, D1
Baldin, G; Belmonti, S; Borghetti, A; Ciccullo, A; De Luca, A; Di Giambenedetto, S; Emiliozzi, A; Gagliardini, R; Lamonica, S; Lombardi, F; Montagnani, F; Moschese, D; Visconti, E1
Acosta, EP; Berzins, B; Godfrey, C; Gulick, RM; Haas, DW; Nyaku, AN; Olefsky, M; Sax, PE; Sha, BE; Smith, KY; Taiwo, BO; Van Dam, CN; Wallis, CL; Zheng, L1
Abebo, TA; Altaye, AA; Asfaw, FT; Bekele, FB; Hibistu, DT; Kebede, HG; Laelago, T; Lukas, K; Tesfaye, DJ; Turuse, EA1
Chasela, C; Ellington, SR; Hosseinipour, M; Hyde, L; Jamieson, DJ; Kayira, D; Kourtis, AP; van der Horst, C; Wiener, J1
Abgrall, S; Antinori, A; Cavassini, M; Costagliola, D; Crane, HM; Gill, MJ; Gomez Sirvent, JL; Guest, JL; Ingle, SM; Manzardo, C; May, MT; Mercie, P; Mugavero, MJ; Phillips, A; Reekie, J; Reiss, P; Saag, MS; Samji, H; Stephan, C; Sterling, TR; Sterne, JA; Tate, J; Wasmuth, JC1
Crowe, SM; David, M; Gare, J; Hearps, AC; Imara, U; Kaima, P; Kelly-Hanku, A; Kombati, Z; Ryan, CE; Siba, PM; Timbi, D1
Borsa-Lebas, F; Cacoub, P; Carrat, F; Fillion, A; Lacombe, K; Lopes, A; Loustaud-Ratti, V; Miailhes, P; Piroth, L; Pol, S; Rosenthal, E; Salmon, D1
Boissonnault, M; Charest, L; Galanakis, C; Huchet, E; Longpré, D; Machouf, N; Murphy, D; Thomas, R; Trottier, B; Vézina, S1
Alioni, S; Izudi, J; Kerukadho, E; Ndungutse, D1
Asari, V; Baxter, C; Garrett, N; Grobler, A; Karim, QA; Karim, SSA; Majola, N; Naicker, N; Naidoo, A; Werner, L1
Bessong, PO; Gachara, G; Kimbi, HK; Lum, E; Magoro, T; Mavhandu, L; Ndip, RN1
Chung, MH; John-Stewart, GC; Kiarie, JN; Kinuthia, J; Lehman, DA; Njiri, F; Overbaugh, J; Richardson, BA1
Boutté, P; Monpoux, F; Pitelet, G; Richelme, C1
Baxter, L; Bryant, J; Hird, S1
Averbuch, D; Engelhard, D; Jaouni, T; Pe'er, J1
Krämer, A; Prüfer-Krämer, L; Wörmann, T1
Gutiérrez, F; López, N; Masiá, M; Padilla, S; Ramos, JM; Robledano, C1
Dia, AT; Diallo, PD; Gaye, AM; Sow, PG1
Atun, R; Ben-Smith, A; Chimbwandira, F; Chirwa, Z; Gilks, CF; Harries, AD; Jahn, A; Lynen, L; Makombe, SD; Meguid, T; Midiani, D; Mnthambala, A; Schouten, EJ; Shawa, M; Van Damme, W; van Oosterhout, JJ; Zachariah, R; Zolfo, M1
Donnelly, J1
Ananthakrishnan, S; Garg, A; Levine, D1
Chintedze, J; Cohen, MS; Corbett, A; Hosseinipour, M; Kashuba, AD; Kumwenda, W; Malunga, G; Mkandawire, N; Moses, A; Phiri, G; Stanczyk, FZ; Stuart, GS1
Bieniek, B1
Henderson, DK1
Belda, A; Borrás-Blasco, J; Casterá, E; Jiménez, I; López-Montes, L; Rosique-Robles, D1
Bower, M; Dunning, J; Manley, K; Nelson, M1
Adégbidi, H; Atadokpédé, F; Do Ango-Padonou, F; Koudoukpo, C; Yédomon, GH1
Chidziva, E; Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kizito, H; Kyomugisha, H; Munderi, P; Musoke, P; Nalumenya, R; Nathoo, K; Russell, EC; Spyer, M; Tumukunde, D; Walker, AS; Zalwango, E1
Gordon, M; Hampton, J; Johnson, B; Kuritzkes, DR; Marconi, VC; Moosa, MY; Ordonez, C; Sunpath, H; Wu, B1
Burger, DM; Chintu, C; Cook, A; Ferrier, A; Fillekes, Q; Gibb, DM; Kabamba, D; Kankasa, C; Mulenga, V; Thomason, MJ; Walker, AS1
Capeau, J; Danner, SA; Domingo, P; Feeney, ER; Mallon, PW; Reiss, P; van Agtmael, MA; van Vonderen, MG; Villarroya, F; Wit, F1
Loulergue, P; Mir, O1
Bissek, AC; Defo, D; Kouotou, EA; Mboua, JB1
Chotmongkol, V; Pesee, M1
Andreoni, M; Nicastri, E; Sarmati, L1
Carr, A; Cooper, DA; Cunningham, PH; Duncombe, C; Grey, PA; Hecht, FM; Kahn, JO; Kaufmann, GR; Petersen, A; Quan, DC; Smith, DE; Zaunders, JJ1
Everall, IP; Foster, R; Olajide, D1
Clanton, TL; Diaz, PT; Drake, J; Nagaraja, HN; Pacht, E; Wewers, MD1
Bouhour, D; Dumouchel-Champagne, H; Durupt, F; Ferry, T; Granier, P1
Crabb, C1
Bertoletti, A; Gilson, RJ; Lascar, RM; Lopes, AR; Maini, MK1
do Lago, RF; Harrison, LH; Mendelsohn, AB; Moreira, RI; Moulton, LH; Schechter, M1
Barberá, MJ; Barceló, JJ; Ferrer, E; Gallart, T; García, A; García, F; Gatell, JM; Lacarcel, M; Maleno, MJ; Martínez, C; Miró, JM; Plana, M; Podzamczer, D1
Beliaeva, VV; Bogoslovskaia, EV; Kravchenko, AV; Miroshnichenko, AV; Serebrovskaia, LV; Sitdykova, IuR1
Garweg, JG; Koerner, UB; Sarra, GM; Schulz, D1
Ascurra, O; Gomani, P; Harries, AD; Humblet, P; Manzi, M; Nunn, P; Salaniponi, FM; Teck, R; Zachariah, R1
Farthing, C; Guyer, B; Khanlou, H1
Murthy, AK; Shah, I1
Riley, LE; Yawetz, S1
Eilers, E; Feiterna-Sperling, C; Obladen, M; Schmitz, T; Weizsaecker, K1
Gładysz, A; Knysz, B; Rzeszutko, M; Zalewska, M1
Ahlenstiel, G; Altfeld, M; Kaufmann, DE; Kupfer, B; Lichterfeld, M; Mui, SK; Rockstroh, JK; Spengler, U; Vogel, M; Voigt, E; Walker, B1
Hirsch, HH; Mossdorf, E1
Rimland, D; Rouphael, NG; Talati, NJ1
Anastos, K; Cohen, M; Cole, S; Hessol, NA; Justman, J; Kaplan, RC; Lu, D; Shi, Q; Tien, PC; Vigen, C; Young, M1
Giry, C; Hebert, JC; Lartigau-Roussin, C; Malvy, D; Pettinelli, ME; Receveur, MC1
Daniel, MJ; Donn, KH; Evans, GL; Hall, ST; Harker, AJ; Hussey, EK1
Evans, GL; Harker, AJ; Hawley, AE; Morris, DM1
Chou, TC; Hirsch, MS; Merrill, DP; Moonis, M1
Boucher, CA; Cammack, N; Hill, A; Ingrand, D; Loveday, C; Robert, C; Weber, J1
Eron, JJ; Hussey, EK; Martin, D; Moore, KH; Mydlow, PK; Raasch, RH; Yuen, GJ1
Bloor, S; Harrigan, PR; Kemp, SD; Kinghorn, I; Kohli, A; Larder, BA; Nájera, I1
Eisen, JA; Katzenstein, DA; Merigan, TC; Shafer, RW1
Clavel, F; Dupont, B; Fournier, S; Moulignier, A; Pialoux, G; Poveda, JD1
Gómez-Cano, M; Soriano, V1
Koopmans, PP; ter Hofstede, HJ; van Haelst, UJ1
Bai, J; Daar, ES; Giorgi, JV; Hausner, MA; Majchrowicz, M; Tamaddon, M1
Agut, H; Bonmarchand, M; Brun-Vezinet, F; Calvez, V; Costagliola, D; Coutellier, A; De Sa, M; Descamps, D; Katlama, C; Lancar, R; Longuet, C; Matheron, S; Tubiana, R; Valantin, MA1
Collazos, J; Martínez, E; Mayo, J1
Kempf-Durepaire, G; Krantz, V; Lang, JM; Nicolle, M; Partisani, M; Rey, D; Schmitt, AC; Schmitt, MP1
Baron, F; Daniel, C; Moutschen, M1
Fine, N; Hurwitz, JJ; Rachlis, AR1
Bloch, M; Carr, A; Cunningham, P; Smith, D; Vasak, E1
Chapman, S; Clendeninn, NJ; Powderly, WG; Quart, B; Saag, MS; Yu, G1
Duro, G; García, C; Hernández-Burruezo, JJ; Martín-Rubio, A; Omar, M; Romero, MD1
Bentwich, Z; Berrebi, A; Klepfish, A; Schattner, A; Shtalrid, M; Shvidel, L1
Bellet, H; Bessis, D; Brunel, M; Callis, A; Faucherre, V; Guilhou, JJ; Vallat, C1
Kennedy, I; Williams, S1
Badia, X; Benavides, A; Coma, A; López Lavid, C; Pinto, JL1
La Seta Catamancio, S; Parker, D; Rusconi, S; Sheridan, F1
Clotet, B; Del Romero, J; Leal, M; Pérez-Olmeda, M; Rodríguez, C; Rubio, A; Ruiz, L; Soriano, V1
Arendt, G; Hefter, H; Theisen, A; von Giesen, HJ1
Briones, C; del Romero, J; Hertogs, K; Pérez-Olmeda, M; Rodríguez, C; Soriano, V1
Amaro, J; Bienvenu, L; Burel, F; Hofman, P; Hofman, V; Itchaï, C1
Abbadessa, V; Andreoni, M; D'Ettorre, G; Dalle, NE; Gallo, I; Mancino, G; Narciso, P; Nicastri, E; Parisi, SG; Sarmati, L; Traina, C; Vullo, V1
Andrews, L; Friedland, GH; Jatlow, P; Lane, B; McCance-Katz, EF; Mitchell, SM; Rainey, PM; Snidow, JW1
Schechter, M1

Reviews

10 review(s) available for lamivudine and AIDS Seroconversion

ArticleYear
An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor-based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1.
    AIDS research and therapy, 2023, 03-22, Volume: 20, Issue:1

    Topics: Anti-HIV Agents; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV Seropositivity; HIV-1; Humans; Lamivudine; RNA; Tablets

2023
Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
    The Cochrane database of systematic reviews, 2023, 06-12, Volume: 6

    Topics: Antiviral Agents; Coinfection; DNA, Viral; Emtricitabine; Female; Hepatitis B e Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnant Women; Ritonavir; Tenofovir; Zidovudine

2023
Non-occupational postexposure prophylaxis for HIV: a systematic review.
    Health technology assessment (Winchester, England), 2009, Volume: 13, Issue:14

    Topics: Anti-HIV Agents; Cost-Benefit Analysis; Databases, Bibliographic; Drug Combinations; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Lopinavir; Premedication; Pyrimidinones; Ritonavir; Substance Abuse, Intravenous; Time Factors; Treatment Outcome; Unsafe Sex; Zidovudine

2009
Antiretroviral therapy-induced psychosis: case report and brief review of the literature.
    HIV medicine, 2003, Volume: 4, Issue:2

    Topics: Adult; Antipsychotic Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Female; Hallucinations; HIV Seropositivity; Humans; Lamivudine; Nevirapine; Psychoses, Substance-Induced; Zidovudine

2003
Evolution of HIV-1-related conjunctival molluscum contagiosum under HAART: report of a bilaterally manifesting case and literature review.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2004, Volume: 242, Issue:11

    Topics: Adult; Antiretroviral Therapy, Highly Active; Conjunctival Diseases; Drug Combinations; Eye Infections, Viral; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Molluscum Contagiosum; Zidovudine

2004
Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2005, Volume: 9, Issue:3

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Drug Therapy, Combination; Drug Utilization; HIV Seropositivity; Humans; Lamivudine; Malawi; National Health Programs; Nevirapine; Prevalence; Rural Population; Stavudine; Tuberculosis; World Health Organization

2005
Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature.
    AIDS (London, England), 2007, Mar-30, Volume: 21, Issue:6

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; HIV Seropositivity; Humans; Lamivudine; Middle Aged; Organophosphonates; Tenofovir

2007
[Resistance to antiretroviral drugs].
    Medicina clinica, 1997, Oct-25, Volume: 109, Issue:14

    Topics: Antiviral Agents; Drug Resistance; Drug Resistance, Multiple; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nevirapine; Point Mutation; Retroviridae; Retroviridae Infections; Zidovudine

1997
Occupational exposure to HIV and post-exposure prophylaxis in healthcare workers.
    Occupational medicine (Oxford, England), 2000, Volume: 50, Issue:6

    Topics: Anti-HIV Agents; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Exposure; Reverse Transcriptase Inhibitors; United Kingdom; Zidovudine

2000
HIV vaccine evaluation center in Rio de Janeiro, Brazil.
    Vaccine, 2002, May-06, Volume: 20, Issue:15

    Topics: Adolescent; Adult; AIDS Vaccines; Anti-HIV Agents; Behavior Therapy; Bisexuality; Brazil; Clinical Trials, Phase II as Topic; Disease Transmission, Infectious; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Incidence; Lamivudine; Male; Middle Aged; Safety; Sensitivity and Specificity; Zidovudine

2002

Trials

21 trial(s) available for lamivudine and AIDS Seroconversion

ArticleYear
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).
    Viruses, 2022, 03-04, Volume: 14, Issue:3

    Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; Lamivudine; Male; Oxazines; Piperazines; Pyridones; Sexual and Gender Minorities; Viral Load

2022
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial.
    The Journal of antimicrobial chemotherapy, 2018, 07-01, Volume: 73, Issue:7

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Oxazines; Piperazines; Pyridones; RNA, Viral; Viral Load

2018
Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phas
    The lancet. HIV, 2018, Volume: 5, Issue:7

    Topics: Adult; Aged; Amides; Anti-HIV Agents; Dideoxynucleosides; Double-Blind Method; Drug Substitution; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Emtricitabine; Female; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Sustained Virologic Response; Tenofovir; Viral Load; Young Adult

2018
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353.
    The Journal of antimicrobial chemotherapy, 2019, 05-01, Volume: 74, Issue:5

    Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Mutation; Oxazines; Pilot Projects; Piperazines; Pyridones; RNA, Viral; Treatment Failure; Viral Load; Young Adult

2019
Health outcomes of HIV-exposed uninfected African infants.
    AIDS (London, England), 2013, Mar-13, Volume: 27, Issue:5

    Topics: Anti-Retroviral Agents; Antiviral Agents; Breast Feeding; Cause of Death; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Morbidity; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Zidovudine

2013
Efficacy and safety of tenofovir-containing antiretroviral therapy in women who acquired HIV while enrolled in tenofovir gel prophylaxis trials.
    Antiviral therapy, 2017, Volume: 22, Issue:4

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Patient Safety; Pregnancy; Primary Prevention; RNA, Viral; South Africa; Tenofovir; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Viral Load; Zidovudine

2017
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Antiviral therapy, 2008, Volume: 13, Issue:6

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Treatment Outcome; Zidovudine

2008
Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi.
    Journal of acquired immune deficiency syndromes (1999), 2011, Oct-01, Volume: 58, Issue:2

    Topics: Adult; Anti-HIV Agents; Area Under Curve; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Feasibility Studies; Female; HIV Seronegativity; HIV Seropositivity; Humans; Lamivudine; Levonorgestrel; Malawi; Nevirapine; Norgestrel; Ovulation Inhibition; Progesterone; Stavudine; Young Adult

2011
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    PLoS medicine, 2012, Volume: 9, Issue:5

    Topics: Abortion, Spontaneous; Adenine; Adult; Anti-HIV Agents; Body Height; Body Weight; Breast Feeding; Burns; Cause of Death; Child, Preschool; Congenital Abnormalities; Drug Combinations; Female; Follow-Up Studies; Fractures, Bone; Growth; HIV Infections; HIV Seropositivity; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Measles; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Respiratory Tract Infections; Tenofovir; Uganda; Zidovudine; Zimbabwe

2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
    AIDS (London, England), 2012, Sep-10, Volume: 26, Issue:14

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Infant; Infant, Newborn; Lamivudine; Male; Nevirapine; Stavudine; Viral Load; Zambia

2012
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
    AIDS (London, England), 2012, Nov-13, Volume: 26, Issue:17

    Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Atrophy; CD4 Lymphocyte Count; DNA, Mitochondrial; Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Subcutaneous Fat; Treatment Outcome; Young Adult; Zidovudine

2012
Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion.
    AIDS research and human retroviruses, 2003, Volume: 19, Issue:3

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Nelfinavir; Prospective Studies; RNA, Viral; Viral Load; Zidovudine

2003
Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.
    The Journal of infectious diseases, 2003, Dec-15, Volume: 188, Issue:12

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Hepatitis B; Hepatitis B virus; HIV Seropositivity; HIV-1; Humans; Lamivudine; Species Specificity; T-Lymphocytes; Viral Load

2003
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
    Antiviral therapy, 2004, Volume: 9, Issue:2

    Topics: Adult; Aged; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Lamivudine; Lymphocyte Activation; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Zidovudine

2004
Efficacy of tenofovir as intensification of zidovudine/lamivudine/abacavir fixed-dose combination in the treatment of HIV-positive patients.
    Journal of acquired immune deficiency syndromes (1999), 2005, Apr-15, Volume: 38, Issue:5

    Topics: CD4 Lymphocyte Count; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Retrospective Studies; RNA, Viral; Viral Load; Zidovudine

2005
Interspecies scaling and pharmacokinetic parameters of 3TC in humans.
    Journal of clinical pharmacology, 1994, Volume: 34, Issue:10

    Topics: Animals; Antiviral Agents; Body Weight; Cross-Over Studies; Dogs; HIV Seropositivity; Humans; Infusions, Intravenous; Lamivudine; Male; Rats; Reverse Transcriptase Inhibitors; Species Specificity; Zalcitabine

1994
Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group.
    AIDS (London, England), 1995, Volume: 9, Issue:12

    Topics: Adult; AIDS-Related Complex; Antigen-Antibody Complex; Antiviral Agents; Dose-Response Relationship, Drug; HIV; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viremia; Zalcitabine

1995
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole.
    Clinical pharmacology and therapeutics, 1996, Volume: 59, Issue:5

    Topics: Administration, Oral; Adult; Analysis of Variance; Anti-Infective Agents; Antiviral Agents; CD4 Lymphocyte Count; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Female; HIV Seropositivity; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Trimethoprim, Sulfamethoxazole Drug Combination; Zalcitabine

1996
Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection.
    AIDS (London, England), 2001, Mar-09, Volume: 15, Issue:4

    Topics: Adult; Anti-HIV Agents; Central Nervous System Diseases; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Motor Skills; Stavudine; Zalcitabine; Zidovudine

2001
Combination shows reduction in viral levels.
    AIDS patient care and STDs, 1996, Volume: 10, Issue:3

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV; HIV Protease Inhibitors; HIV Seropositivity; Humans; Indinavir; Lamivudine; Time Factors; Zidovudine

1996
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations.
    Journal of medical virology, 2001, Volume: 65, Issue:4

    Topics: Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Mutation; Stavudine; Treatment Failure; Zidovudine

2001

Other Studies

82 other study(ies) available for lamivudine and AIDS Seroconversion

ArticleYear
Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression.
    The Journal of antimicrobial chemotherapy, 2022, 05-29, Volume: 77, Issue:6

    Topics: Drug Resistance, Viral; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV Seropositivity; HIV-1; Humans; Integrases; Lamivudine; Leukocytes, Mononuclear; Male; Oxazines; Piperazines; Pyridones; RNA-Directed DNA Polymerase; Viremia

2022
Dolutegravir Plus Lamivudine as Initial Therapy for HIV-1 Infected and ARV-naïve Patients in West China, 24-Weeks Results of a Preliminary Real-world Study.
    Current HIV research, 2022, Volume: 20, Issue:3

    Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B Surface Antigens; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Oxazines; Piperazines; Pyridones; RNA; RNA, Viral; Viral Load

2022
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study.
    The lancet. HIV, 2022, Volume: 9, Issue:8

    Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Drug Resistance; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Malawi; Oxazines; Piperazines; Prospective Studies; Pyridones; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load

2022
Dolutegravir Plus Lamivudine Dual-Drug Regimen in Treatment-Naive HIV-1-Infected Patients With High-Level Viral Load: Preliminary Data From the Real World.
    Journal of acquired immune deficiency syndromes (1999), 2022, 10-01, Volume: 91, Issue:S1

    Topics: Anti-HIV Agents; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Oxazines; Piperazines; Preliminary Data; Prospective Studies; Pyridones; Retrospective Studies; RNA, Viral; Viral Load

2022
Performance of Creatinine- and Cystatin C-Based Equations for Glomerular Filtration Rate Estimation in HIV-1-Infected Individuals Receiving Dolutegravir + Tenofovir Disoproxil Fumarate + Lamivudine as Initial Antiretroviral Therapy: A Retrospective Observ
    Journal of acquired immune deficiency syndromes (1999), 2022, 10-01, Volume: 91, Issue:S1

    Topics: Adult; Creatinine; Cystatin C; Female; Glomerular Filtration Rate; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Oxazines; Piperazines; Pyridones; Renal Insufficiency, Chronic; Retrospective Studies; Tenofovir

2022
Efficacy and Safety of a Simplified Lamivudine Plus Dolutegravir Dual Therapy in HIV-1-Infected Patients: A Multicenter Cohort Study in China.
    Journal of acquired immune deficiency syndromes (1999), 2022, 10-01, Volume: 91, Issue:S1

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Retrospective Studies; Sexual and Gender Minorities

2022
Economic evaluation of doravirine/tenofovir disoproxil fumarate/lamivudine for HIV-1-infected adults in Russia: a cost-minimization and budget impact analysis.
    Expert review of pharmacoeconomics & outcomes research, 2022, Volume: 22, Issue:8

    Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Drug Combinations; Drugs, Essential; Emtricitabine; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; RNA, Viral; Tenofovir; Viral Load

2022
Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014.
    Journal of acquired immune deficiency syndromes (1999), 2023, 02-01, Volume: 92, Issue:2

    Topics: Adolescent; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Child; Emtricitabine; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Pyridones; RNA, Viral; Tablets; Tenofovir

2023
Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Adolescent; Anti-HIV Agents; Cameroon; Drug Resistance, Viral; Follow-Up Studies; Health Facilities; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nevirapine; Retrospective Studies; Viral Load; Zidovudine

2022
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV.
    Viruses, 2023, 04-10, Volume: 15, Issue:4

    Topics: Anti-HIV Agents; Drug-Related Side Effects and Adverse Reactions; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Retrospective Studies; Rilpivirine

2023
Doravirine responses to HIV-1 viruses bearing mutations to NRTIs and NNRTIs under in vitro selective drug pressure.
    The Journal of antimicrobial chemotherapy, 2023, 08-02, Volume: 78, Issue:8

    Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Rilpivirine

2023
Assessing the Virologic Impact of Archived Resistance in the Dolutegravir/Lamivudine 2-Drug Regimen HIV-1 Switch Study TANGO through Week 144.
    Viruses, 2023, 06-11, Volume: 15, Issue:6

    Topics: Anti-HIV Agents; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load

2023
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens.
    Viruses, 2023, 08-02, Volume: 15, Issue:8

    Topics: Cameroon; HIV Seropositivity; HIV-1; Humans; Lamivudine; Tenofovir

2023
HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis.
    The lancet. HIV, 2023, Volume: 10, Issue:11

    Topics: Cohort Studies; Drug Resistance, Viral; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV Seropositivity; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors

2023
Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women: Drug monitoring application to improve patient safety.
    Medicine, 2020, May-29, Volume: 99, Issue:22

    Topics: Adult; Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Female; HIV Seropositivity; Humans; Lamivudine; Lopinavir; Patient Safety; Pregnancy; Ritonavir; Tandem Mass Spectrometry; Viral Load; Zidovudine

2020
Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa.
    BMC infectious diseases, 2020, Jul-22, Volume: 20, Issue:1

    Topics: Administration, Oral; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Resistance, Viral; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Epidemics; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine; Pre-Exposure Prophylaxis; Retrospective Studies; South Africa; Treatment Outcome; Viral Load; Young Adult; Zidovudine

2020
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding.
    Journal of acquired immune deficiency syndromes (1999), 2021, 11-01, Volume: 88, Issue:3

    Topics: Anti-HIV Agents; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Retrospective Studies; RNA

2021
Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain.
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2017, Sep-01, Volume: 41, Issue:5

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cost-Benefit Analysis; Dideoxynucleosides; Drug Combinations; Drug Compounding; Female; Heterocyclic Compounds, 3-Ring; HIV Seropositivity; Humans; Lamivudine; Male; Oxazines; Piperazines; Pyridones; Reverse Transcriptase Inhibitors; Spain

2017
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice.
    BMC infectious diseases, 2019, Jan-17, Volume: 19, Issue:1

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cohort Studies; Darunavir; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Retrospective Studies; Ritonavir; Tenofovir; Treatment Outcome; Viral Load

2019
Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia.
    BMC pregnancy and childbirth, 2019, Feb-28, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Developing Countries; Directive Counseling; Drug Therapy, Combination; Ethiopia; Female; Health Services Accessibility; HIV Seropositivity; Hospitals, Public; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Medication Adherence; Pregnancy; Prenatal Care; Surveys and Questionnaires; Tenofovir; Time Factors; Travel; Young Adult

2019
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009.
    AIDS (London, England), 2013, Mar-13, Volume: 27, Issue:5

    Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Europe; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lopinavir; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir; Time Factors; United States

2013
Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:8

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dried Blood Spot Testing; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Papua New Guinea; Reverse Transcriptase Inhibitors; Stavudine; Treatment Failure; Viral Load; Young Adult; Zidovudine

2014
Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:8

    Topics: Adult; Antiviral Agents; Cohort Studies; Comorbidity; Disease Progression; Female; France; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Reference Values; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Tenofovir; Treatment Outcome

2015
Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Humans; Incidence; Lamivudine; Lopinavir; Male; Medication Adherence; Middle Aged; Post-Exposure Prophylaxis; Quebec; Ritonavir; Tenofovir; Young Adult; Zidovudine

2015
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda.
    BMC infectious diseases, 2016, Oct-28, Volume: 16, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Weight; CD4-Positive T-Lymphocytes; Cohort Studies; Cyclopropanes; Disclosure; Female; HIV Infections; HIV Seropositivity; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Nevirapine; Retrospective Studies; Tenofovir; Treatment Outcome; Uganda

2016
Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    AIDS research and therapy, 2017, Mar-08, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Base Sequence; Cameroon; Child, Preschool; Coinfection; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Male; Middle Aged; Mutation; Phylogeny; Prevalence; Prospective Studies; Risk Factors; Sequence Analysis; Young Adult

2017
[A case of acquired encephalopathy in a child. A cause that we thought had disappeared].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2008, Volume: 15, Issue:12

    Topics: AIDS Dementia Complex; Anti-HIV Agents; Anti-Infective Agents; Drug Therapy, Combination; Female; Fluconazole; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Polymerase Chain Reaction; Pyrimidinones; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine

2008
Confluent molluscum contagiosum covering the eyelids of an HIV-positive child.
    Clinical & experimental ophthalmology, 2009, Volume: 37, Issue:5

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Drug Therapy, Combination; Eye Infections, Viral; Eyelid Diseases; HIV Seropositivity; Humans; Lamivudine; Male; Molluscum Contagiosum; Nevirapine; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Zidovudine

2009
[Serological and sociodemographic differences in HBV-patients with and without migration background].
    Zeitschrift fur Gastroenterologie, 2010, Volume: 48, Issue:5

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Comorbidity; Cross-Sectional Studies; Educational Status; Emigrants and Immigrants; Female; Germany; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Seropositivity; Humans; Incidence; Lamivudine; Liver Function Tests; Male; Middle Aged; Organophosphonates; Outpatient Clinics, Hospital; Socioeconomic Factors; Unemployment; Viral Load; Young Adult

2010
Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir.
    AIDS research and human retroviruses, 2012, Volume: 28, Issue:3

    Topics: Adenine; Adult; Anti-HIV Agents; Bone Density; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Female; Follow-Up Studies; HIV Seropositivity; Humans; Lamivudine; Longitudinal Studies; Male; Organophosphonates; Parathyroid Hormone; Tenofovir; Vitamin D; Vitamin D Deficiency

2012
[Comparative study of two anti-antiretroviral protocols used for treatment of a cohort of HIV 1-positive patients followed at the Institute of Public Health and Hygiene in Dakar, Senegal].
    Medecine tropicale : revue du Corps de sante colonial, 2011, Volume: 71, Issue:2

    Topics: Academies and Institutes; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Seropositivity; HIV-1; Humans; Hygiene; Lamivudine; Nevirapine; Public Health; Quality of Life; Retrospective Studies; Senegal; Survival Analysis; Treatment Outcome; Zidovudine

2011
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach.
    Lancet (London, England), 2011, Jul-16, Volume: 378, Issue:9787

    Topics: Adult; Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; Goals; Healthy People Programs; HIV Infections; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Male; Nevirapine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Public Health; United Nations; Zidovudine

2011
Battles with donors cloud Malawi's HIV prevention plan.
    Lancet (London, England), 2011, Jul-16, Volume: 378, Issue:9787

    Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Charities; Cyclopropanes; Drug Costs; Drug Therapy, Combination; Female; Health Policy; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; International Cooperation; Lamivudine; Malawi; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir

2011
Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:4

    Topics: Adenine; Adrenal Insufficiency; Adult; Atazanavir Sulfate; Cushing Syndrome; Cytochrome P-450 Enzyme Inhibitors; Female; HIV Protease Inhibitors; HIV Seropositivity; Humans; Iatrogenic Disease; Injections, Intramuscular; Lamivudine; Oligopeptides; Organophosphonates; Pruritus; Pyridines; Ritonavir; Tenofovir; Triamcinolone Acetonide

2011
[Raltegravir in a special case: patient with HIV and Burkitt's lymphoma].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:41

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; CD4 Lymphocyte Count; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Administration Schedule; Duodenal Neoplasms; HIV Seropositivity; Humans; Intestine, Small; Lamivudine; Lymphoma, AIDS-Related; Male; Pyrrolidinones; Raltegravir Potassium; Remission Induction; Viral Load

2011
Management of needlestick injuries: a house officer who has a needlestick.
    JAMA, 2012, Jan-04, Volume: 307, Issue:1

    Topics: Anti-HIV Agents; Blood-Borne Pathogens; Drug Combinations; Emergency Service, Hospital; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Internship and Residency; Lamivudine; Male; Needlestick Injuries; Occupational Exposure; Physicians; Post-Exposure Prophylaxis; Risk; United States; Zidovudine

2012
Hyperhidrosis related to nevirapine therapy.
    International journal of STD & AIDS, 2012, Volume: 23, Issue:1

    Topics: Adenine; Aged; Anti-HIV Agents; Drug Eruptions; HIV Seropositivity; Humans; Hyperhidrosis; Lamivudine; Male; Nevirapine; Organophosphonates; Tenofovir

2012
HIV-associated gastric natural killer/T-cell lymphoma.
    International journal of STD & AIDS, 2012, Volume: 23, Issue:1

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Atazanavir Sulfate; Cyclophosphamide; Doxorubicin; Female; HIV Seropositivity; Humans; Lamivudine; Lymphoma, Extranodal NK-T-Cell; Oligopeptides; Prednisone; Pyridines; Pyrrolidinones; Raltegravir Potassium; Stomach Neoplasms; Vincristine

2012
[Erosive and budding molluscum contagiosum: total regression under antiretroviral therapy].
    Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:3

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Benin; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Lamivudine; Molluscum Contagiosum; Nevirapine; Stavudine

2012
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen.
    AIDS (London, England), 2012, Aug-24, Volume: 26, Issue:13

    Topics: Adenine; Adult; Arginine; CD4 Lymphocyte Count; Cohort Studies; Drug Resistance, Viral; Female; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lysine; Male; Mutation; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; South Africa; Stavudine; Tenofovir; Treatment Failure; Viral Load

2012
Letter to the editor: Hypersensitivity to lamivudine and emtricitabine.
    Current HIV research, 2012, Volume: 10, Issue:7

    Topics: Aged; Anti-HIV Agents; Deoxycytidine; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Therapy, Combination; Emtricitabine; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine

2012
[A case of vitiligo occurring after initiation of antiretroviral treatment and disappearing during this treatment: autoimmune IRIS syndrome?].
    Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:11

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Male; Viral Load; Vitiligo; Zidovudine

2012
AIDS-related primary central nervous system lymphoma: prolonged remission associated with highly active antiretroviral therapy.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2002, Volume: 85, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Brain Neoplasms; HIV Seropositivity; Humans; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Male; Radiography; Stavudine; Ventriculoperitoneal Shunt

2002
Stavudine protective function and emergence of Lamivudine resistance.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:3

    Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Seropositivity; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine

2003
Respiratory symptoms among HIV-seropositive individuals.
    Chest, 2003, Volume: 123, Issue:6

    Topics: Adult; Anti-HIV Agents; Cough; Cross-Sectional Studies; Dyspnea; HIV Seropositivity; Humans; Lamivudine; Respiratory Function Tests; Respiratory System; Smoking; Surveys and Questionnaires

2003
[Hypersensitive reaction to abacavir or syphilitic hepatitis?].
    Presse medicale (Paris, France : 1983), 2003, Oct-11, Volume: 32, Issue:33

    Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Ethylenediamines; HIV Seropositivity; Humans; Lamivudine; Male; Syphilis; Zidovudine

2003
Breastfeeding and HIV transmission.
    AIDS (London, England), 2003, Nov-21, Volume: 17, Issue:17

    Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Seropositivity; Humans; Infant; Lamivudine; Nevirapine; Risk Factors

2003
Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV.
    Journal of acquired immune deficiency syndromes (1999), 2004, Apr-15, Volume: 35, Issue:5

    Topics: Adult; Anti-HIV Agents; Brazil; Chemoprevention; Cohort Studies; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Lamivudine; Male; Patient Acceptance of Health Care; Sexual Behavior; Surveys and Questionnaires; Zidovudine

2004
[Antiretroviral therapy of acute HIV-infection].
    Terapevticheskii arkhiv, 2004, Volume: 76, Issue:4

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Lymphocyte Count; Male; Nevirapine; Viral Load; Zidovudine

2004
Aplastic anemia in an HIV infected child.
    Indian journal of pediatrics, 2005, Volume: 72, Issue:4

    Topics: Adolescent; Anemia, Aplastic; Anti-HIV Agents; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Female; HIV Seropositivity; Humans; Lamivudine; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Transfusion Reaction; Treatment Outcome

2005
Case records of the Massachusetts General Hospital. Case 32-2005. A 34-year-old HIV-positive woman who desired to become pregnant.
    The New England journal of medicine, 2005, Oct-20, Volume: 353, Issue:16

    Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cesarean Section; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Papillomaviridae; Papillomavirus Infections; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Uterine Cervicitis; Viral Load; Zidovudine

2005
Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates.
    AIDS (London, England), 2006, Apr-24, Volume: 20, Issue:7

    Topics: Anti-HIV Agents; Enterocolitis, Necrotizing; HIV Seropositivity; Humans; Infant, Newborn; Lamivudine; Male; Nevirapine; Risk Factors; Zidovudine

2006
Lung cancer as an immune reconstitution disease in an HIV-1 positive man receiving HAART.
    Postepy higieny i medycyny doswiadczalnej (Online), 2006, Volume: 60

    Topics: Adult; Antiretroviral Therapy, Highly Active; Carcinoma, Small Cell; Fatal Outcome; HIV Seropositivity; Humans; Lamivudine; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Ritonavir; Saquinavir; Zidovudine

2006
Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.
    European journal of medical research, 2006, Jul-31, Volume: 11, Issue:7

    Topics: Acute Disease; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; Follow-Up Studies; Histocompatibility Testing; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Retrospective Studies; RNA, Viral; Stavudine; Treatment Outcome; Zidovudine

2006
[Adherence, pharmacokinetic "tolerance capacity" and HIV resistance development].
    Praxis, 2006, Aug-16, Volume: 95, Issue:33

    Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Diagnosis, Differential; DNA Mutational Analysis; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Nelfinavir; Treatment Refusal; Viral Load; Zidovudine

2006
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.
    Journal of acquired immune deficiency syndromes (1999), 2007, May-01, Volume: 45, Issue:1

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Black People; Cholesterol; Cross-Sectional Studies; Cyclopropanes; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Fasting; Female; Hispanic or Latino; HIV Infections; HIV Protease Inhibitors; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Multivariate Analysis; Nelfinavir; Nevirapine; Organophosphonates; Ritonavir; Stavudine; Tenofovir; Triglycerides; United States; White People

2007
[Update on HIV infection in Mayotte].
    Medecine tropicale : revue du Corps de sante colonial, 2007, Volume: 67, Issue:2

    Topics: Adult; Anti-HIV Agents; Comoros; Dideoxynucleosides; Drug Combinations; Female; Heterosexuality; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Lamivudine; Male; Middle Aged; Transfusion Reaction; Viremia; Zidovudine

2007
High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum.
    Journal of chromatography. B, Biomedical applications, 1994, Jul-01, Volume: 657, Issue:1

    Topics: Antiviral Agents; Autoanalysis; Chromatography, High Pressure Liquid; Dideoxynucleosides; HIV Seropositivity; Hot Temperature; Humans; Lamivudine; Quality Control; Sensitivity and Specificity; Zalcitabine

1994
Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro.
    The Journal of infectious diseases, 1996, Volume: 173, Issue:2

    Topics: Antiviral Agents; Drug Combinations; Drug Synergism; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Stavudine; Virus Replication; Zalcitabine

1996
Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility.
    Journal of virology, 1996, Volume: 70, Issue:9

    Topics: Antiviral Agents; Codon; Drug Therapy, Combination; Genetic Variation; HeLa Cells; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Point Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Virus Replication; Zalcitabine; Zidovudine

1996
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
    Journal of virology, 1997, Volume: 71, Issue:7

    Topics: Adult; Amino Acid Sequence; Base Sequence; Didanosine; DNA, Viral; Female; Genes, env; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nevirapine; Nucleic Acid Heteroduplexes; Phylogeny; Pyridines; Reverse Transcriptase Inhibitors; Sequence Homology, Amino Acid; Zidovudine; Zimbabwe

1997
Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir.
    AIDS (London, England), 1997, Volume: 11, Issue:10

    Topics: Anti-HIV Agents; Central Nervous System; Dideoxynucleosides; Drug Therapy, Combination; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zidovudine

1997
Two-in-one tablet eases 'pill burden'.
    The American journal of nursing, 1997, Volume: 97, Issue:11

    Topics: Anti-HIV Agents; Drug Combinations; HIV Seropositivity; Humans; Lamivudine; Zidovudine

1997
[Hepatic steatosis during treatment with zidovudine and lamivudine in an HIV-positive patient].
    Nederlands tijdschrift voor geneeskunde, 1998, Feb-21, Volume: 142, Issue:8

    Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Fatty Liver; HIV Seropositivity; Humans; Lamivudine; Male; Transaminases; Zidovudine

1998
Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion.
    Annals of internal medicine, 1998, May-15, Volume: 128, Issue:10

    Topics: Adult; Anti-HIV Agents; CD4-CD8 Ratio; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Male; Ritonavir; RNA, Viral; T-Lymphocytes, Cytotoxic; Zidovudine

1998
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.
    Annals of internal medicine, 1998, Oct-01, Volume: 129, Issue:7

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Pilot Projects; Prospective Studies; RNA, Viral; Stavudine; Viral Load

1998
Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy.
    AIDS (London, England), 1998, Sep-10, Volume: 12, Issue:13

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Seropositivity; Humans; Indinavir; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Male; Viral Load; Zidovudine

1998
[Weak antiviral effect of changing two nucleoside analogues combined with antiretroviral agents. 3TC and d4T after ZDU and ddi or ddc].
    Presse medicale (Paris, France : 1983), 1998, Feb-28, Volume: 27, Issue:8

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Retrospective Studies; Stavudine; Viral Load; Zalcitabine; Zidovudine

1998
[Clinical case of the month. Apropos of pancytopenia in a seropositive patient].
    Revue medicale de Liege, 1998, Volume: 53, Issue:12

    Topics: Adult; Anemia, Aplastic; Anti-HIV Agents; Bone Marrow; HIV Infections; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Male; Pancytopenia; Stavudine; Zidovudine

1998
Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1999, Volume: 34, Issue:4

    Topics: Anti-HIV Agents; Dacryocystorhinostomy; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Male; Middle Aged; Needlestick Injuries; Occupational Exposure; Ophthalmology; Primary Prevention; Risk Factors; Zidovudine

1999
The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination.
    American journal of obstetrics and gynecology, 1999, Volume: 181, Issue:3

    Topics: Adult; Antiviral Agents; Female; HIV Infections; HIV Seropositivity; Humans; Indinavir; Insemination, Artificial, Heterologous; Lamivudine; Male; Pregnancy; Tissue Donors; Zidovudine

1999
Predictors of optimal virological response to potent antiretroviral therapy.
    AIDS (London, England), 1999, Oct-01, Volume: 13, Issue:14

    Topics: Adult; Anti-HIV Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; HIV Protease Inhibitors; HIV Seropositivity; Humans; Lamivudine; Male; Nelfinavir; Outcome Assessment, Health Care; Predictive Value of Tests; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Zidovudine

1999
[Pustulous psoriasis resistant to conventional treatment].
    Enfermedades infecciosas y microbiologia clinica, 1999, Volume: 17, Issue:8

    Topics: Adult; Antiviral Agents; Drug Resistance; Drug Therapy, Combination; HIV Seropositivity; Humans; Lamivudine; Male; Psoriasis; Saquinavir; Zidovudine

1999
Advanced Hodgkin's disease in a pregnant HIV seropositive woman: favorable mother and baby outcome following combined anticancer and antiretroviral therapy.
    American journal of hematology, 2000, Volume: 63, Issue:1

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; HIV Seropositivity; Hodgkin Disease; Humans; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Remission Induction; Stavudine; Zidovudine

2000
[Cutaneous porphyria cure in a patient infected with human immunodeficiency virus treated with triple therapy].
    La Revue de medecine interne, 2000, Volume: 21, Issue:3

    Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Hepatitis C; HIV Seropositivity; Humans; Indinavir; Lamivudine; Male; Opioid-Related Disorders; Porphyria Cutanea Tarda; Remission, Spontaneous; Stavudine

2000
[Cost effectiveness analysis of highly active antiretroviral therapy in HIV asymptomatic patients].
    Medicina clinica, 2000, Volume: 114 Suppl 3

    Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Didanosine; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nevirapine; Sickness Impact Profile; Spain; Stavudine; Viral Load; Zidovudine

2000
A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2000, Volume: 19, Issue:3

    Topics: Anti-HIV Agents; Codon; Didanosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nucleic Acid Hybridization; Point Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zalcitabine; Zidovudine

2000
Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.
    Journal of medical virology, 2001, Volume: 63, Issue:2

    Topics: Anti-HIV Agents; Codon; Drug Resistance, Microbial; Genotype; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Lamivudine; Mutation; Polymorphism, Genetic; Prevalence; Reverse Transcriptase Inhibitors; Spain; Zidovudine

2001
Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.
    Journal of acquired immune deficiency syndromes (1999), 2001, Feb-01, Volume: 26, Issue:2

    Topics: Drug Resistance, Microbial; Drug Resistance, Multiple; Genotype; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Mutation; Phenotype; Protease Inhibitors; Reverse Transcriptase Inhibitors; Spain; Viral Load; Zidovudine

2001
Potent new AIDS drugs underscore promise of combination therapy.
    AIDS alert, 1996, Volume: 11, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Drug Approval; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; Humans; Isoquinolines; Lamivudine; Quinolines; Saquinavir; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine

1996
[A rare etiology of hepatic steatosis associated with lactic acidosis: the toxicity of antiviral nucleoside analogues].
    Annales de pathologie, 2001, Volume: 21, Issue:2

    Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Antimetabolites; Didanosine; Fatal Outcome; Fatty Liver; Female; HIV Seropositivity; Humans; Lamivudine; Microscopy, Electron; Mitochondria, Liver; Stavudine; Zidovudine

2001
The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects.
    The American journal on addictions, 2002,Winter, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Anti-HIV Agents; Drug Combinations; Female; HIV Seropositivity; Humans; Lamivudine; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Zidovudine

2002